Top Research Reports for ASML, Alibaba & Intuitive Surgical

Monday, November 9, 2026

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ASML Holding N.V. (ASML), Alibaba Group Holding Ltd. (BABA), Intuitive Surgical, Inc. (ISRG) as well as two micro-cap stocks, Paul Mueller Co. (MUEL) and Presurance Holdings, Inc. (PRHI). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> Jensen Huang News Dominates Market Headlines

Today's Featured Research Reports

ASML’s shares have outperformed the Zacks Semiconductor Equipment - Wafer Fabrication industry over the past year (+37.2% vs. +35.3%). Per the Zacks analyst, the company benefits from strong AI-driven demand for advanced Logic and Memory capacity, rising lithography intensity and sustained demand for EUV, DUV and installed-base services. High-NA adoption further strengthens its technology leadership, while higher volumes, upgrades and improved product mix support profitability.

However, growth depends on sustained customer capital spending and successful production expansion. Export-control uncertainty surrounding China remains a risk, while the timing of broader High-NA adoption is still uncertain.

(You can read the full research report on ASML here >>>)

Alibaba’s shares have underperformed the Internet - Commerce industry over the last six months (-20.2% vs. -4.4%). The Zacks analyst believes that the company faces elevated investment requirements, slower China commerce monetization and continued spending on quick commerce and AI development. Heavy infrastructure outlays and uneven core-commerce trends constrain near-term returns.

Yet, its broad commerce ecosystem, growing AI-driven cloud demand and deeper consumer-platform integration offer attractive long-term growth opportunities. Better operating discipline and expanding AI applications further strengthen its prospects.

(You can read the full research report on Alibaba here >>>)

Intuitive Surgical’s shares have underperformed the Medical - Instruments  industry over the past year (-21.4% vs. +3.1%). The Zacks analyst believes that the company faces moderating U.S. procedure growth, weak bariatric volumes and intensifying competition and pricing pressures in China. Tariffs, product mix, hospital budget constraints and extended-use instruments could also weigh on margins and revenue growth.

However, its broad robotic platform, expanding installed base and recurring revenue model support durable growth. Adoption of Da Vinci 5, SP and Ion systems, healthy procedure demand and digital innovation strengthen its long-term prospects.

(You can read the full research report on Intuitive Surgical here >>>)

Paul Mueller’s shares have outperformed the Zacks Manufacturing - General Industrial industry over the past two years (+120.1% vs. -3.5%). The Zacks analyst believes that the company benefits from a sizable Industrial Equipment backlog, sustained demand and improving international contributions. Capacity expansion, modest leverage and continued shareholder returns further strengthen its investment case.

Yet, project mix, labor efficiency, contractor reliance and delivery schedules create execution risks. Rising working-capital needs, weaker cash conversion and exposure to dairy regulations and currency movements could constrain margin recovery.

(You can read the full research report on Paul Mueller here >>>)

Presurance’s shares have outperformed the Zacks Insurance - Multi Line industry over the last six months (+53.0% vs. +10.3%). The Zacks analyst believes that the company benefited from improved underwriting discipline and stronger profitability. Its strategic shift toward personal insurance and improved claims management have supported better operating performance, while strengthened capital resources have also aided.

However, the company’s business has contracted as it exits legacy commercial insurance lines, reducing premium volume. Cash outflows, regulatory capital constraints and a smaller operating scale remain concerns.

(You can read the full research report on Presurance here >>>)

Other noteworthy reports we are featuring today include Arista Networks, Inc. (ANET), Canadian Natural Resources Ltd. (CNQ) and Cintas Corp. (CTAS).

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Alibaba (BABA) Gains From International Commerce Businesses

ASML Rides on Higher AI Investments, Healthy Demand Trends

Strong Demand for Intuitive Surgical's (ISRG) da Vinci 5 Boosts Growth

Featured Reports

Insmed (INSM) Rides on Sales Uptake for Bronchiectasis Drug
The Zacks analyst is encouraged by demand for Insmed's Brinsupri, the first non-CF bronchiectasis therapy. The drug is expected to reach blockbuster status in 2026, its first full sales year, 2026.

LNG Expansion & Utility Investments Fuel Sempra (SRE) Growth
According to the Zacks analyst, Sempra benefits from growing global LNG demand, a $65B infrastructure investment plan through 2030, and expanding renewable energy assets, supporting long-term growth.

Canadian Natural (CNQ) to Gain from Oil Sands Mining and Upgrading
The Zacks analyst believes Canadian Natural's Oil Sands Mining and Upgrading operations generate some of the strongest margins in the industry and provides high return opportunities.

AI Innovation & Client Retention Aid Paychex (PAYX), Competition High
Per the Zacks analyst, Paychex benefits from AI-driven innovation and strong client retention. However, intense competition and continued investment requirements may pressure profitability.

Power Systems Strength Aids Cummins (CMI) Amid Engine Weakness
Cummins benefits from strong Power Systems unit growth, driven by robust data center demand. However, weakness in North American pickup truck engine demand remains a concern.

Uniform Rental Unit Aids Cintas (CTAS) Amid Rising Costs
Per the Zacks analyst, Cintas' Uniform Rental & Facility Services unit is driven by high customer retention and penetration of additional products into existing customers. High costs remain a concern.

Growing Data Center Demand Aids Carrier (CARR) Amid Housing Weakness
Per the Zacks analyst, Carrier is benefiting from strong demand for data center projects, HVAC business and portfolio optimization. However, elevated input costs and a weak residential market hurt.

New Upgrades

U.S. Supply Mix, Better Collections, Liquidity to Aid Encore Capital
Per the Zacks analyst, favorable U.S. supply, better collection technology, disciplined European deployment, cheaper funding and rising capital returns will support Encore Capital's profitability.

Arista (ANET) Rides on Solid Momentum in AI Infrastructure Space
Per the Zacks analyst, rising investment in AI, cloud and enterprise networking as customers expand high-speed Ethernet infrastructure will likely drive Arista's top line.

Life Science Expansion Aids Innovative Industrial (IIPR) Amid Defaults
Per the Zacks analyst, Innovative Industrial benefits from high-yield IQHQ and Alewife investments and re-leasing momentum. Cannabis market growth and long leases underpin rising recurring cash flows.

New Downgrades

Corteva's (CTVA) Pricing Pressure Could Limit Margin Expansion
Per the Zacks analyst, Corteva's persistent pricing pressure and rising operating expenses could limit margin expansion, despite volume growth, productivity gains and new product adoption.

Fidelity National (FIS) Faces Growth Headwinds and Debt Risks
Per the Zacks analyst, Fidelity National faces delayed client conversions, bank consolidation and weaker license demand, while rising cybersecurity spending and elevated debt pressure its outlook.

Rising Costs and Execution Risks Threaten IonQ's (IONQ) Outlook
The Zacks analyst worries about IonQ's rising operating costs, heavy cash burn and acquisition integration risks, which could delay profitability despite rapid revenue growth and expanding demand.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research